APA (7th ed.) Citation

RJ, B., H, C. H., D, W., GP, C., JC, P., & RJ, S. (2026). Phospho-enol pyruvate carboxykinase inhibition limits effector function in inflammatory T cells. Frontiers in immunology, 17, 1706167. https://doi.org/10.3389/fimmu.2026.1706167

Chicago Style (17th ed.) Citation

RJ, Brownlie, Carrasco Hope H, Wright D, Cook GP, Perales JC, and Salmond RJ. "Phospho-enol Pyruvate Carboxykinase Inhibition Limits Effector Function in Inflammatory T Cells." Frontiers in Immunology 17 (2026): 1706167. https://doi.org/10.3389/fimmu.2026.1706167.

MLA (9th ed.) Citation

RJ, Brownlie, et al. "Phospho-enol Pyruvate Carboxykinase Inhibition Limits Effector Function in Inflammatory T Cells." Frontiers in Immunology, vol. 17, 2026, p. 1706167, https://doi.org/10.3389/fimmu.2026.1706167.